Taysha Gene Therapies, Inc. (TSHA)
6.015
-0.18
(-2.98%)
USD |
NASDAQ |
Aug 26, 16:00
6.14
+0.12
(+2.08%)
After-Hours: 20:00
Taysha Gene Therapies Total Assets (Quarterly) : 470.43M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 470.43M |
| March 31, 2026 | 300.35M |
| December 31, 2025 | 483.73M |
| September 30, 2025 | 316.55M |
| June 30, 2025 | 333.33M |
| March 31, 2025 | 138.36M |
| December 31, 2024 | 276.41M |
| September 30, 2024 | 180.22M |
| June 30, 2024 | 200.39M |
| March 31, 2024 | 153.00M |
| December 31, 2023 | 266.99M |
| September 30, 2023 | 195.77M |
| June 30, 2023 | 81.54M |
| Date | Value |
|---|---|
| March 31, 2023 | 101.60M |
| December 31, 2022 | 128.63M |
| September 30, 2022 | 111.47M |
| June 30, 2022 | 142.33M |
| March 31, 2022 | 165.98M |
| December 31, 2021 | 213.96M |
| September 30, 2021 | 241.04M |
| June 30, 2021 | 241.86M |
| March 31, 2021 | 242.83M |
| December 31, 2020 | 258.88M |
| September 30, 2020 | 279.27M |
| June 30, 2020 | 11.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Altimmune, Inc. | 527.21M |
| Protalix Biotherapeutics, Inc. | 110.34M |
| Humacyte, Inc. | 138.09M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 83.17M |
| Shareholders Equity (Quarterly) | 387.27M |
| Debt to Equity Ratio | 0.1469 |
| Current Ratio | 17.76 |
| Net Debt Paydown Yield | 0.05% |